SR-17018 is an experimental research compound belonging to a class of drugs called "biased agonists" of the μ-opioid receptor. It is designed to relieve pain without triggering the dangerous side effects commonly associated with traditional opioids like morphine or fentanyl. It is also very effective in reducing tolerance to, or fully quitting, other opioids. It does not have any recreational value.